Baxano Surgical Inc  

(Public, OTCMKTS:BAXSQ)   Watch this stock  
Find more results for NASDAQ:TSON
-0.00140 (-31.82%)
Feb 27 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.00 - 0.00
52 week 0.00 - 1.75
Open 0.00
Vol / Avg. 127,625.00/492,561.00
Mkt cap 149,175.00
P/E     -
Div/yield     -
EPS -0.68
Shares 49.73M
Beta 0.37
Inst. own 35%

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin -126.01% -172.35%
Operating margin -167.40% -171.15%
EBITD margin - -138.00%
Return on average assets -56.63% -78.84%
Return on average equity -117.23% -126.62%
Employees 139 -
CDP Score - -


110 Horizon Dr Ste 230
RALEIGH, NC 27615-4927
United States - Map
+1-919-8000020 (Phone)
+1-800-2535177 (Fax)

Website links


Baxano Surgical Inc, formerly TranS1 Inc., is a medical device company focused on designing, developing and marketing products that implement its approach to treat degenerative conditions of the spine affecting the lower lumbar region. It develops its pre-sacral approach to allow spine surgeons to access and treat intervertebral spaces without compromising important surrounding soft tissue, nerves and bone structures. As of December 31, 2011, the Company was marketing the AxiaLIF family of products for single and multilevel lumbar fusion, the Vectre and Avatar lumbar posterior fixation systems and Bi-Ostetic bone void filler, a biologics product. All of the Company�s AxiaLIF products are delivered using its pre-sacral approach. It generates revenue from the sales of itsimplants and disposable surgical instruments. It has two distinct sales methods.

Officers and directors

Paul A. LaViolette Independent Chairman of the Board
Age: 56
Kenneth Reali President, Chief Executive Officer, Director
Age: 48
Greg D. Slusser Vice President - Commercial Operations
Age: 52
Greg Welsh Vice President - Operations
Age: 51
Mukesh Ramchandani Vice President and General Manager, International
Age: 48
Matthew Pickens Vice President - Marketing and Reimbursement
Age: 40
Stephanie M. Fitts Ph.D. Vice President - Regulatory, Quality and Compliance
Age: 47
Stephen D. Ainsworth Ph.D. Vice President - Research & Development
Age: 44
Jeffrey Fischgrund M.D. Independent Director
Age: 53
James M. Shapiro Independent Director
Age: 56